July 01, 2026 article Open access Expert viewpoint on endpoints in systemic sclerosis: current and future outlook RMD Open DOI: 10.1136/rmdopen-2026-006784 Full text (OA) OpenAlex Authors 0 Author list not loaded yet. Cited by 0 stored of 0 References 2 Search Sort Most cited Newest Oldest Patent citations Title Any typearticle review book-chapter conference-paper preprint dissertation book dataset other Any fieldAgricultural and Biological Sciences Arts and Humanities Biochemistry, Genetics and Molecular Biology Business, Management and Accounting Chemical Engineering Chemistry Computer Science Decision Sciences Dentistry Earth and Planetary Sciences Economics, Econometrics and Finance Energy Engineering Environmental Science Health Professions Immunology and Microbiology Materials Science Mathematics Medicine Neuroscience Nursing Pharmacology, Toxicology and Pharmaceutics Physics and Astronomy Psychology Social Sciences Veterinary Open access Disease progression in systemic sclerosis 2020 Lara D. Veeken article Medicine Systemic Sclerosis and Related Diseases Open access 18 citations A Phase II study of avenciguat, a novel soluble guanylate cyclase activator, in patients with systemic sclerosis: Study design and rationale of the VITALISScE™ study 2024 Journal of Scleroderma and Related Disorders article Medicine Systemic Sclerosis and Related Diseases Open access 8 citations 2 results